# TREVARX BIOMEDICAL, INC.: Preparing for Phase I IND For Paradigm Shifting Alpha Radiotherapy [211At]PTT to Treat Ovarian Cancer

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | TREVARX BIOMEDICAL, INC. |
| Location | PHILADELPHIA, PA |
| Project | Preparing for Phase I IND For Paradigm Shifting Alpha Radiotherapy [211At]PTT to Treat Ovarian Cancer |
| Project number | 1R44CA310342-01A1 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,174,824 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-21 to 2028-08-31 |
| UEI | PC6KVBCJAPK9 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11408032). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.